首页|Third People’s Hospital Reports Findings in Liver Cancer (Komboknife combined w ith sorafenib in liver cancer treatment: Efficacy and safety under immune functi on influence)
Third People’s Hospital Reports Findings in Liver Cancer (Komboknife combined w ith sorafenib in liver cancer treatment: Efficacy and safety under immune functi on influence)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Oncology - Liver Cance r is the subject of a report. According to newsreporting originating in Zhengzh ou, People’s Republic of China, by NewsRx journalists, research stated,“In the quest to manage hepatocellular carcinoma (HCC), the focus has shifted to a more holistic approachencompassing both data analytics and innovative treatments. An alyzing rich data resources, such as thecancer genome atlas (TCGA), and examini ng progressive therapies can potentially reshape the trajectoryof HCC treatment .”
ZhengzhouPeople’s Republic of ChinaA siaAntineoplasticsCancerCyborgsDrugs and TherapiesEmerging Technologie sGeneticsHealth and MedicineLiver CancerMachine LearningMultikinase In hibitorsOncologyPharmaceuticalsSorafenib TherapyTyrosine Kinase Inhibito rsVEGF - VEGFR InhibitorsVEGFR Inhibitors
NETL
NSTL
